Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -183.87M | $ -8.75 | 1 | 21.01M |
3/31/2025 | $ -153.16M | $ -7.31 | 1 | 20.94M |
12/31/2024 | $ -130.93M | $ -6.62 | 1 | 19.78M |
9/30/2024 | $ -95.24M | $ -4.56 | 1 | 20.88M |
6/30/2024 | $ -100.98M | $ -4.84 | 1 | 20.85M |
3/31/2024 | $ -113.99M | $ -6.92 | 1 | 16.48M |
12/31/2023 | $ -118.24M | $ -11.73 | 1 | 10.08M |
9/30/2023 | $ -126.11M | $ -12.49 | 1 | 10.1M |
6/30/2023 | $ -133.36M | $ -13.23 | 1 | 10.08M |
3/31/2023 | $ -145.61M | $ -14.52 | 1 | 10.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: EBIT [ $ -98.8M ] / (Shares WA [ 8.89M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -11.12 ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.8K |
---|---|
min | $ -9.77 |
max | $ 10.86 |
average | $ 1.17 |
median | $ 0.39 |
std | $ 3.44 |